Phibro Historical Cash Flow
| PAHC Stock | USD 24.14 0.40 1.68% |
Analysis of Phibro Animal cash flow over time is an excellent tool to project Phibro Animal Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 23.3 M or Other Non Cash Items of 24.4 M as it is a great indicator of Phibro Animal ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Phibro Animal Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Phibro Animal Health is a good buy for the upcoming year.
Phibro |
About Phibro Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Phibro balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Phibro's non-liquid assets can be easily converted into cash.
Phibro Animal Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Phibro Animal Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Phibro Animal operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Phibro Animal's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Phibro Animal Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At present, Phibro Animal's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 48.7 M, whereas Other Cashflows From Financing Activities is projected to grow to (29.4 K).
Phibro Animal cash flow statement Correlations
Click cells to compare fundamentals
Phibro Animal Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phibro Animal cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (12.9M) | (12.5M) | (47.0M) | (11.2M) | 2.6M | 2.8M | |
| Change In Cash | (21.2M) | 13.9M | 24.0M | (33.0M) | 29.3M | 30.8M | |
| Free Cash Flow | 25.3M | 19.0M | (5.4M) | (38.5M) | 46.4M | 48.7M | |
| Change In Working Capital | (13.7M) | (29.9M) | (44.6M) | (41.1M) | 33.1M | 34.8M | |
| Other Cashflows From Financing Activities | 243M | 614.6M | 292.2M | 329.7M | (31K) | (29.5K) | |
| Depreciation | 32.3M | 31.9M | 32.7M | 34.0M | 36.2M | 23.3M | |
| Other Non Cash Items | (3.3M) | (7.0M) | (4.8M) | 1.1M | 23.3M | 24.4M | |
| Capital Expenditures | 34.0M | 29.3M | 37.0M | 51.8M | 41.2M | 23.8M | |
| Total Cash From Operating Activities | 59.3M | 48.3M | 31.6M | 13.3M | 87.6M | 92.0M | |
| Net Income | 33.6M | 54.4M | 49.2M | 32.6M | 2.4M | 2.3M | |
| Total Cash From Financing Activities | 40.9M | (17.0M) | 16.3M | 27.0M | (6.8M) | (6.4M) | |
| End Period Cash Flow | 36.3M | 50.2M | 74.2M | 41.3M | 70.6M | 36.1M | |
| Other Cashflows From Investing Activities | (55.3M) | (1.3M) | (12.9M) | 776K | 698.4K | 733.3K | |
| Begin Period Cash Flow | 57.6M | 36.3M | 50.2M | 74.2M | 41.3M | 34.3M | |
| Change To Account Receivables | 28.7M | (18.2M) | (23.6M) | 5.3M | (8.7M) | (8.2M) | |
| Change To Liabilities | (16.2M) | 3.2M | 29.5M | (28.6M) | (25.7M) | (24.4M) | |
| Total Cashflows From Investing Activities | (120.4M) | (18.6M) | (22.6M) | (74.0M) | (66.6M) | (63.3M) | |
| Dividends Paid | 18.6M | 19.4M | 19.4M | 19.4M | 17.5M | 15.8M | |
| Change Receivables | 28.7M | (18.2M) | (23.6M) | 5.3M | 6.1M | 6.4M | |
| Net Borrowings | 60.4M | 5.4M | 50M | 41.2M | 47.4M | 49.8M | |
| Exchange Rate Changes | (536K) | (524K) | (1.1M) | 1.1M | 1.3M | 1.4M | |
| Cash And Cash Equivalents Changes | (21.2M) | 13.9M | 25.4M | (33.7M) | (30.3M) | (28.8M) | |
| Cash Flows Other Operating | (15.7M) | (3.5M) | (3.2M) | (6.7M) | (6.0M) | (6.3M) | |
| Change To Operating Activities | (21.8M) | (2.3M) | (373K) | (12.4M) | (11.2M) | (10.6M) | |
| Change To Netincome | 8.7M | (8.9M) | (6.5M) | (12.9M) | (11.6M) | (11.0M) | |
| Investments | (31M) | 12M | 27.4M | (23M) | (48.2M) | (50.6M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.